文献速递乳腺外科围术期管理与 ERAS

乳腺手术静脉血栓栓塞症标准化风险评估与分层预防

Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation.
PubMed 文献 · J Am Coll Surg · 2019-12-04

低中危组无VTE事件,高危组5例(1.3%)、极高危组1例(1.6%);出院后发生VTE的5例均未接受推荐的延长药物预防。延长药物预防未增加出血风险。

要点

  • Caprini工具可识别乳腺手术高危VTE患者及无需药物预防的低危患者。
  • 高危和极高危组VTE发生率分别为1.3%和1.6%,低中危组为0。
  • 延长药物预防未增加出血风险。

核心结论

  • Caprini方案可识别可能受益于延长VTE药物预防的高危乳腺手术患者,以及无需药物预防的低危患者。
  • 延长药物预防与出血风险增加无关。

主要发现

  • 48.9%为低或中危,43.8%为高危,7.3%为极高危。
  • 低中危组无VTE事件,高危组5例(1.3%),极高危组1例(1.6%)。
  • 1例在住院期间诊断VTE;出院后发生VTE的5例均未接受推荐的延长药物预防。
  • 19例出血事件无需再次手术,3例返回手术室;出血与接受延长药物预防无相关性。

关键数值与推荐

  • 低中危组无VTE事件,高危组VTE发生率1.3%,极高危组1.6%。
  • 出院后VTE的5例均未接受推荐的延长药物预防。

临床怎么用

  • 对乳腺手术患者采用Caprini风险评估进行VTE风险分层,高危和极高危患者可考虑延长药物预防,低危患者无需药物预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) prophylaxis has become routine for patients undergoing most operations, but it remains controversial for breast operations due to a perceived low risk of VTE. There is limited evidence to support routine or extended VTE prophylaxis in breast surgery. We investigated the benefits and risks of the Caprini risk stratification tool and corresponding prevention program, including extended prophylaxis for high-risk groups, in patients undergoing operations for benign and malignant breast lesions. STUDY DESIGN: Using Boston Medical Center data, we reviewed records of patients who underwent lumpectomy or total mastectomy (with or without axillary surgery and/or reconstruction), between 2011 and 2018, to collect information about operation, Caprini score, administration of prophylaxis, and postoperative VTE or bleeding events. Descriptive statistics were performed. RESULTS: Seven hundred fifty patients underwent 881 operations; 48.9% were at low or moderate risk of VTE, 43.8% were at high risk, and 7.3% were at highest risk. There were no VTE events in the low- and moderate-risk groups, 5 (1.3%) in the high-risk, and 1 (1.6%) in the highest-risk group. One patient was diagnosed with VTE during hospitalization. None of the 5 patients who developed VTE after discharge was prescribed the recommended extended chemoprophylaxis. There were 19 bleeding events that did not require reoperation; 3 patients returned to the operating room. There was no correlation of bleeding with receipt of extended chemoprophylaxis. CONCLUSIONS: The Caprini protocol can identify high-risk breast surgery patients who may benefit from extended VTE chemoprophylaxis, as well as low-risk patients who require no chemoprophylaxis. Furthermore, administration of extended chemoprophylaxis was not associated with an increased risk of bleeding.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Kim NE, Conway-Pearson L, Kavanah M, et al. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2019. PMID: 31809861. doi:10.1016/j.jamcollsurg.2019.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。